Table 3

Finger blood flow measured in the unexposed (left) middle finger of 10 healthy subjects before, during and after a 15 minute exposure to static load (contact force 10 N) and vibration with different combinations of frequencies (Hz) and unweighted acceleration magnitudes (m/s2 rms) but with the same frequency weighted acceleration (5.5 m/s2 rms) according to the frequency weighting of ISO 5349

Static load Vibration 16 Hz, 5.5 m/s2 Vibration 31.5 Hz, 11 m/s2 Vibration 63 Hz, 22 m/s2 Vibration 125 Hz, 44 m/s2 Vibration 250 Hz, 88 m/s2
Before exposure23.2 (1.7)28.6 (2.0)27.4 (2.2)26.4 (2.3)24.4 (2.2)26.1 (2.8)
Exposure (min):
 E 0.527.6 (2.8)27.0 (2.0)25.3 (2.1)23.8 (3.1)19.4 (2.0)22.4 (3.0)
+19.5% (−25.0% to 64.0%)−3.0% (−33.4% to 27.4%)−3.5% (−37.2% to 30.3%)−12.1% (−37.8% to 13.7%)−20.6% (−54.8% to 13.5%)−10.9% (−51.6% to 29.7%)
 E 1.527.5 (3.5)27.2 (1.4)22.4 (1.5)24.8 (3.6)22.0 (2.6)23.1 (2.5)
+18.5% (−26.0% to 63.0%)−2.9% (−33.3% to 27.5%)−12.8% (−46.5% to 21.0%)−8.0% (−33.8% to 17.8%)−7.8% (−41.9% to 26.4%)−7.4% (−48.1% to 33.2%)
 E 3.525.9 (3.0)26.1 (1.5)25.9 (2.0)24.5 (2.8)20.5 (2.0)19.8 (2.3)
+13.3% (−31.2% to 57.8%)−6.3% (−36.7% to 24.1%)−2.1% (−35.8% to 31.7%)−6.7% (−32.5% to 19.0%)−12.1% (−46.2% to 22.0%)−23.4% (−64.0% to 17.3%)
 E 5.530.4 (2.9)30.8 (2.6)30.2 (2.8)23.9 (2.8)21.0 (2.7)17.9 (2.3)
+32.5% (−12.0% to 77.0%)+11.9% (−18.5% to 42.3%)+12.7% (−21.1% to 46.4%)−10.1% (−35.8% to 15.7%)−14.7% (−48.8% to 19.4%)−29.4% (−70.1% to 11.2%)
 E 7.529.8 (3.1)25.7 (1.5)25.9 (2.9)23.0 (2.8)24.4 (2.9)19.5 (3.1)
+27.4% (−17.0% to 71.9%)−5.0% (−35.4% to 25.4%)−3.9% (−37.7% to 29.8%)−13.8% (−39.5% to 12.0%)0% (−34.1% to 34.1%)−23.0% (−63.7% to 17.6%)
 E 1532.5 (2.7)25.8 (1.3)27.3 (3.1)21.5 (3.0)18.9 (2.8)19.3 (2.2)
+43.7% (−0.7% to 88.2%)−3.9% (−34.4% to 26.4%)+0.5% (−33.3% to 34.2%)−17.8% (−43.6% to 8.0%)−19.9% (−54.1% to 14.2%)−17.7% (−58.4% to 22.9%)
Recovery (min):
 R 0.528.3 (2.4)29.8 (2.8)29.9 (1.9)27.1 (2.8)24.2 (2.0)29.0 (3.7)
+26.0% (−18.5% to 70.5%)+6.9% (−23.5% to 37.2%)+12.6% (−21.2% to 46.3%)+1.6% (−24.2% to 27.3%)+8.5% (−25.6% to 42.6%)+18.6% (−22.0% to 59.3%)
 R 1.526.7 (2.3)27.5 (1.7)26.8 (2.6)23.9 (2.3)26.4 (2.2)24.0 (2.1)
+15.2% (−29.3% to 59.7%)+1.6% (−28.8% to 32.0)+1.4% (−32.3% to 35.2%)−9.6% (−35.3% to 16.2%)+16.0% (−18.1% to 50.2%)−3.1% (−43.7% to 37.6%)
 R 3.526.6 (2.3)26.3 (1.5)26.9 (2.6)24.8 (2.7)24.3 (2.2)26.2 (1.8)
+18.3% (−26.2% to 62.8%)−3.2% (−33.6% to 27.2%)+1.8% (−31.9% to 35.6%)−5.5% (−31.3% to 20.3%)+3.1% (−31.1% to 37.2%)+10.3% (−30.3% to 51.0%)
 R 5.527.8 (2.6)25.2 (1.3)27.0 (2.2)26.7 (3.2)28.4 (2.4)24.8 (2.7)
+21.4% (−23.1% to 65.9%)−8.4% (−38.8% to 22.0%)+2.1% (−31.7% to 35.8%)−1.0% (−26.7% to 24.7%)+25.5% (−8.6% to 59.7%)+8.8% (−31.9% to 49.5%)
 R 7.526.3 (2.0)26.2 (1.6)25.8 (1.6)27.2 (3.6)23.2 (2.2)23.6 (1.8)
+16.7% (−27.8% to 61.2%)−1.8% (−32.2% to 28.6%)−1.4% (−35.2% to 32.3%)+0.4% (−25.3% to 26.2%)−2.3% (−36.5% to 31.8%)+2.9% (−37.8% to 43.5%)
 R 1527.9 (2.5)24.5 (1.1)25.5 (2.9)27.5 (3.1)21.7 (2.4)23.5 (1.7)
+21.3% (−23.2% to 65.8%)−9.7% (−40.1% to 20.8%)−1.3% (−35.0% to 32.5%)+3.1% (−22.6% to 28.9%)−7.5% (−41.6% to 26.7%)+0.7% (−40.0% to 41.3%)
 R 22.526.8 (2.6)25.3 (0.9)24.7 (1.8)22.2 (2.5)23.0 (2.8)20.1 (1.6)
+18.2% (−26.2% to 62.7%)−6.9% (−37.3% to 23.5%)−3.9% (−37.7% to 29.8%)−15.2% (−40.9% to 10.6%)−1.6% (−35.7% to 32.5%)−15.2% (−55.8% to 25.5%)
 R 3025.6 (2.4)27.0 (1.5)23.3 (2.5)20.7 (2.2)17.0 (1.7)14.7 (1.7)
+12.2% (−32.3% to 56.7%)−1.7% (−32.1% to 28.7%)−9.9% (−43.7% to 23.8%)−20.7% (−46.5% to 5.1%)−24.8% (−58.9% to 9.3%)−41.4% (−0.8% to −82.1%)
 R 37.525.3 (1.9)26.7 (2.0)18.4 (2.8)20.9 (1.6)13.0 (1.3)13.6 (1.2)
+14.5% (−30.0% to 58.9%)−2.5% (−32.9% to 27.9%)−28.7% (−62.5% to 5.0%)−19.1% (−44.9% to 6.7%)−42.3% (−8.2% to −76.5%)−43.7% (−3.0% to −84.3%)
 R 4529.0 (2.9)24.9 (2.1)18.3 (3.1)18.1 (2.0)11.4 (1.2)15.2 (1.8)
+30.7% (−13.7% to 75.2%)−9.3% (−39.7% to 21.1%)−29.9% (−63.6% to 3.9%)−30.5% (−4.7% to −56.3%)−49.7% (−15.6% to −83.9%)−39.1% (−2.5% to −75.7%)
ANCOVA (p value)0.280.330.0140.007<0.00010.0003
  • Mean (SEM) values (ml/100 ml/min) and mean (95% CI) values for the percentage changes in finger blood flow compared with the measures before exposure are also given.

  • p Values of repeated measures analysis of covariance (ANCOVA) are adjusted by age, finger volume, and room temperature.